Evidence map›Paper›PMID 37924476›Full record

ArticleJournal of cancer survivorship : research and practice2025

Depressive symptom trajectories in older breast cancer survivors: the Thinking and Living with Cancer Study.

Zev M Nakamura, Brent J Small, Wanting Zhai, Tim A Ahles, Jaeil Ahn, Ashley L Artese, Traci N Bethea, Elizabeth C Breen, Harvey J Cohen, Martine Extermann and 15 more

Abstract read
In one paragraph

Article in Journal of cancer survivorship : research and practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 13 institutions in 1 country.

Zev M NakamuraDepartment of Psychiatry, University of North Carolina at Chapel Hill, 101 Manning Drive, Campus Box #7160, Chapel Hill, NC, 27599, USA. zev_nakamura@med.unc.edu.
Brent J SmallSchool of Aging Studies, University of South Florida, and Health Outcomes and Behavior Program, Moffitt Cancer Center, Tampa, FL, USA.
Wanting ZhaiDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
Tim A AhlesDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Jaeil AhnDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
Ashley L ArteseCenter for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA.
Traci N BetheaGeorgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA.
Elizabeth C BreenSemel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
Harvey J CohenCenter for the Study of Aging and Human Development, Duke University Medical Center, Durham, NC, USA.
Martine ExtermannDepartment of Oncology, Moffitt Cancer Center, University of South Florida, Tampa, FL, USA.
Deena GrahamJohn Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ, USA.
Michael R IrwinSemel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
Claudine IsaacsGeorgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA.
Heather S L JimDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Kate R KuhlmanCousins Center for Psychoneuroimmunology, University of California, Los Angeles, Los Angeles, CA, USA.
Brenna C McDonaldDepartment of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Sunita K PatelCity of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Kelly E RentscherDepartment of Psychiatry and Behavioral Medicine, MCW Cancer Center, Medical College of Wisconsin, Milwaukee, WI, USA.
James C RootDepartment of Psychiatry and Behavioral Sciences, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Andrew J SaykinDepartment of Radiology and Imaging Sciences, Melvin and Bren Simon Comprehensive Cancer Center, and Indiana Alzheimer's Disease Research Center, Indiana University School of Medicine, Indianapolis, IN, USA.
Danielle B TometichDepartment of Health Outcomes and Behavior, Moffitt Cancer Center, Tampa, FL, USA.
Kathleen Van DykSemel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
Xingtao ZhouDepartment of Biostatistics, Bioinformatics, and Biomathematics, Georgetown University, Washington, DC, USA.
Jeanne S MandelblattGeorgetown Lombardi Institute for Cancer and Aging Research, Lombardi Comprehensive Cancer Center, Department of Oncology, Georgetown University, Washington, DC, USA.
Judith E CarrollSemel Institute for Neuroscience and Human Behavior, Department of Psychiatry & Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA, USA.
Georgetown University · USUniversity of California, Los Angeles · USMoffitt Cancer Center · USMemorial Sloan Kettering Cancer Center · USCity of Hope · USDuke University · USDuke University Hospital · USHackensack University Medical Center · USIndiana University Health · USIndiana University – Purdue University Indianapolis · USMedical College of Wisconsin · USUniversity of North Carolina at Chapel Hill · USUniversity of South Florida · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Tissue Culture Shared ResourceP30CA051008 · NCI · GEORGETOWN UNIVERSITY · PI Louis M Weiner · 1990 to 2026
$71.5M
Research Education ComponentP30AG010133 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI SAYKIN, ANDREW J · 1991 to 2020
$37.3M
Training and Career Development CoreU54CA132378 · NCI · CITY COLLEGE OF NEW YORK · PI Bao Q Vuong · 2008 to 2026
$28.9M
Training and Career Development and Education CoreU54CA137788 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI ADRIANA ESPINOSA, FRANCESCA M GANY · 2008 to 2026
$28.1M
Resource Core 3 - Metabolomics CoreP30AG028716 · NIA · DUKE UNIVERSITY · PI Sarah B. Peskoe · 2006 to 2026
$24.6M
Research Education ComponentP30AG072976 · NIA · INDIANA UNIVERSITY INDIANAPOLIS · PI ANDREW J SAYKIN · 2021 to 2026
$24.1M
BEHAVIOR AND PHYSIOLOGY IN AGINGT32AG000029 · NIA · DUKE UNIVERSITY · PI Maria Marquine · 1985 to 2026
$9.3M
OLDER BREAST CANCER PATIENTS: RISK FOR COGNITIVE DECLINER01CA129769 · NCI · GEORGETOWN UNIVERSITY · PI AHLES, TIM ALAN, MANDELBLATT, JEANNE · 2009 to 2020
$7.3M
Bio-behavioral Research At The Intersection of Cancer and AgingR35CA197289 · NCI · GEORGETOWN UNIVERSITY · PI MANDELBLATT, JEANNE · 2015 to 2021
$6.2M
Leveraging Digital Health Solutions to Reduce Learning and Functional Disparities in Children with Cancer - Diversity SupplementR01CA261793 · NCI · BECKMAN RESEARCH INSTITUTE/CITY OF HOPE · PI Sunita K Patel · 2022 to 2026
$3.9M
Social Determinants of Health as Transducers of Cellular Aging: A New Multi-level Paradigm to Reduce Survivorship Disparities at the Intersection of Cancer and AgingR35CA283926 · NCI · GEORGETOWN UNIVERSITY · PI Jeanne Mandelblatt · 2023 to 2026
$3.7M
NCI NIH HHS K01 CA212056NCI NIH HHS K08 CA241337NCI NIH HHS K99 CA270294NCI NIH HHS P30 CA008748NCI NIH HHS P30 CA051008NCI NIH HHS R00 CA270294NCI NIH HHS R01 CA129769NCI NIH HHS R01 CA172119NCI NIH HHS R01 CA237535NCI NIH HHS R01 CA244673NCI NIH HHS R01 CA261793NCI NIH HHS R35 CA197289NCI NIH HHS R35 CA283926NCI NIH HHS U54 CA132378NCI NIH HHS U54 CA137788NIA NIH HHS K01 AG065485NIA NIH HHS P30 AG010133NIA NIH HHS P30 AG028716NIA NIH HHS P30 AG072976NIA NIH HHS R01 AG068193NIA NIH HHS R01 AG082348NIA NIH HHS R56 AG068086NIA NIH HHS T32 AG000029
6 · The paper itself

Abstract

purposeTo identify trajectories of depressive symptoms in older breast cancer survivors and demographic, psychosocial, physical health, and cancer-related predictors of these trajectories.

methodsRecently diagnosed nonmetastatic breast cancer survivors (n = 272), ages 60-98 years, were evaluated for depressive symptoms (Center for Epidemiological Studies Depression Scale, CES-D; scores ≥16 suggestive of clinically significant depressive symptoms). CES-D scores were analyzed in growth-mixture models to determine depression trajectories from baseline (post-surgery, pre-systemic therapy) through 3-year annual follow-up. Multivariable, multinomial logistic regression was used to identify baseline predictors of depression trajectories.

resultsSurvivors had three distinct trajectories: stable (84.6%), emerging depressive symptoms (10.3%), and recovery from high depressive symptoms at baseline that improved slowly over time (5.1%). Compared to stable survivors, those in the emerging (OR = 1.16; 95% CI = 1.08-1.23) or recovery (OR = 1.26; 95% CI = 1.15-1.38) groups reported greater baseline anxiety. Greater baseline deficit accumulation (frailty composite measure) was associated with emerging depressive symptoms (OR = 3.71; 95% CI = 1.90-7.26). Less social support at baseline (OR = 0.38; 95% CI = 0.15-0.99), but greater improvement in emotional (F = 4.13; p = 0.0006) and tangible (F = 2.86; p = 0.01) social support over time, was associated with recovery from depressive symptoms.

conclusionsFifteen percent of older breast cancer survivors experienced emerging or recovery depressive symptom trajectories. Baseline anxiety, deficit accumulation, and lower social support were associated with worse outcomes. IMPLICATIONS FOR CANCER SURVIVORS: Our results emphasize the importance of depression screening throughout the course of cancer care to facilitate early intervention. Factors associated with depressive symptoms, including lower levels of social support proximal to diagnosis, could serve as intervention levers.

Indexed as

Breast NeoplasmsCancer SurvivorsDepressionAgedAged, 80 and overFemaleHumansMiddle AgedQuality of LifeBreast cancerCancer survivorshipDepressionFrailtyOlder adultsSocial support

Identifiers

PMID37924476
PMCPMC11068856
OpenAlexW4388343065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.